1. Home
  2. SITE vs TLX Comparison

SITE vs TLX Comparison

Compare SITE & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SITE
  • TLX
  • Stock Information
  • Founded
  • SITE 2013
  • TLX 2015
  • Country
  • SITE United States
  • TLX Australia
  • Employees
  • SITE N/A
  • TLX N/A
  • Industry
  • SITE Professional and commerical equipment
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SITE Consumer Discretionary
  • TLX Health Care
  • Exchange
  • SITE Nasdaq
  • TLX Nasdaq
  • Market Cap
  • SITE 5.4B
  • TLX 6.0B
  • IPO Year
  • SITE 2016
  • TLX N/A
  • Fundamental
  • Price
  • SITE $121.34
  • TLX $16.76
  • Analyst Decision
  • SITE Buy
  • TLX Strong Buy
  • Analyst Count
  • SITE 9
  • TLX 1
  • Target Price
  • SITE $155.11
  • TLX $22.00
  • AVG Volume (30 Days)
  • SITE 473.8K
  • TLX 31.6K
  • Earning Date
  • SITE 04-30-2025
  • TLX 01-01-0001
  • Dividend Yield
  • SITE N/A
  • TLX N/A
  • EPS Growth
  • SITE N/A
  • TLX 798.14
  • EPS
  • SITE 2.71
  • TLX 0.09
  • Revenue
  • SITE $4,540,600,000.00
  • TLX $484,687,790.00
  • Revenue This Year
  • SITE $7.36
  • TLX N/A
  • Revenue Next Year
  • SITE $4.76
  • TLX N/A
  • P/E Ratio
  • SITE $44.77
  • TLX $187.85
  • Revenue Growth
  • SITE 5.57
  • TLX 55.85
  • 52 Week Low
  • SITE $114.60
  • TLX $14.01
  • 52 Week High
  • SITE $181.81
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • SITE 39.55
  • TLX N/A
  • Support Level
  • SITE $117.88
  • TLX N/A
  • Resistance Level
  • SITE $129.37
  • TLX N/A
  • Average True Range (ATR)
  • SITE 3.83
  • TLX 0.00
  • MACD
  • SITE 0.38
  • TLX 0.00
  • Stochastic Oscillator
  • SITE 30.07
  • TLX 0.00

About SITE SiteOne Landscape Supply Inc.

SiteOne Landscape Supply Inc is a supplier of tools and equipment. The company serves various businesses which include wholesale irrigation, outdoor lighting, nursery, landscape supplies, grass seeds, and fertilizers, turf protection products, turf care equipment, and golf course accessories for green industry professionals mainly in the United States and Canada. Its product portfolio includes irrigation supplies, fertilizer and herbicides, landscape accessories, nursery goods, natural stones and blocks, outdoor lighting and ice melt products and other products.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: